Abstract
Despite the availability of several antihypertensive drug classes and numerous individual agents, hypertension remains poorly controlled in many patients. Improving control rates will require tailoring of therapy to individual patient factors. In a recent issue of the American Journal of Hypertension , three studies address the heterogeneity of response to various antihypertensive drugs, and two editorialists use the findings to propose novel treatment paradigms. Two studies highlight inter-individual responses to treatment. Turner and colleagues found that measures of plasma renin activity (PRA) predicted patient responses to …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
